One Capital Management’s AstraZeneca AZN Stock Holding History

One Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$263K	Hold	1,335	–	–	0.01%	470
2026 Q1	$263K	Buy	+1,335	New	+$257K	0.01%	470
2014 Q4	–	Sell	-2,310	Closed	-$165K	–	167
2014 Q3	$165K	Buy	+2,310	New	+$169K	0.06%	142

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

One Capital Management's AZN Position: Q2 2026 in Review

One Capital Management held its AstraZeneca (AZN) position steady in Q2 2026 at 1,335 shares worth $263K. The position accounts for 0.01% of the portfolio, ranked #470.

One Capital Management first reported a position in AZN in Q3 2014 and has held it in 3 quarters since. 1,498 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

One Capital Management held 1,335 shares of AstraZeneca worth $263K as of Q2 2026.
One Capital Management left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.01% of One Capital Management's portfolio in Q2 2026, its #470 holding.
One Capital Management first reported a position in AstraZeneca in Q3 2014 and has held it in 3 quarters since.
1,498 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on One Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.